Global Molecular Diagnostics Industry Trends and Forecasts Analysis

Over the years, medical science has made unprecedented progress in almost every sphere of human anatomy. In the pursuit, pathological sciences, in particular, have brought forth advancements that rendered the possibility of deploying certain tests that are performed on patient samples, including blood and tissues, in order to detect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Essentially, In-vitro Diagnostics (IVD) have earned the title of ‘silent champion’ of the healthcare industry since this segment influences more than half of the decision-making in the overall healthcare industry.


Under this umbrella, the fastest growing segment, i.e. molecular diagnostics, involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of health or disease. Such diagnostic methods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and specificity and thus, have been receiving greater inclination from physicians and affiliates. 

Complete report available at http://www.marketreportsonline.com/347275.html.

The molecular diagnostics procedures for infectious diseases including CT/NG, HPV; encompasses four major disciplines: Virology, Bacteriology, Genetics and Blood Screening. Due to certain underlying factors, the oncology segment of the market is poised to undergo noteworthy expansion in the near future and thereby driving the molecular diagnostics market on the holistic basis. As of now, the global molecular diagnostics market is characterized by growth in large value mergers and acquisitions, personalized treatment in the field of oncology and reimbursement trend.

The report presents thorough analysis of the global molecular diagnostics market and its various segments and also provides detailed information pertaining to its superset market, i.e. the diagnostics and the IVD industry. It further discusses the various trends, growth drivers and challenges faced by the industry. In addition to the market contention prevalent in the global molecular diagnostics market, major industry players including Roche Holdings, Novartis, Hologic and Qiagen are profiled herein.

Purchase a copy of this research report at USD 800 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=347275.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have projected the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output.

Major points from Table of Contents
1. Diagnostics: An Overview
2. Diagnostics Market
3. Market Dynamics
4. Competitive Landscape
5. Company Profiles
6. Market Outlook
List of Tables
List of Charts

Explore more reports on Healthcare Market at http://www.marketreportsonline.com/cat/healthcare-market-research.html.

About Us:
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
Corporate Office
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.
Tel: + 1 888 391 5441
E-mail: sales@marketreportsonline.com

Comments

Popular posts from this blog

MarketReportsOnline: Indonesia Rubber Industry Analysis

Latest Guide to Chinese Pharmaceutical GMP Regulations

Construction in Bahrain – Key Trends and Opportunities to 2015